EXCERPT
November 2024 – Post of the acquisition from Legacy Pharma CEO, Mark Thompson “Very pleased to announce that Legacy has acquired a basket of products from Sebela Pharmaceuticals including Naftin. After this acquisition, Legacy has 22 prescription products sold in various therapeutic categories throughout the United States.”
